3-Acetylpyridine (EBC-03180)
Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
152459-95-5
Purity
95%
Imatinib is an oral chemotherapy medication used to treat cancer. It is a tyrosine kinases inhibitor that selectively inhibits BCR/ABL, v-Abl, PDGFR and c-kit kinase activity.
Properties
Name
Imatinib
Smiles
CN1CCN(CC=2C=CC(=CC2)C(=O)NC=3C=CC(C)=C(NC=4N=CC=C(N4)C=5C=CC=NC5)C3)CC1
Targets
Please log in to see this information
SDS
Gleevac | IKT-001 | NSC 759854 | ST-1571 | STI-571 | gleevec | glivec | imatinib | imitinib
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$19
2 mg
$19
5 mg
$19
10 mg
$19
15 mg
$19
20 mg
$19
25 mg
$19
30 mg
$19
35 mg
$19
40 mg
$19
45 mg
$19
50 mg
$19
75 mg
$19
100 mg
$POA
Quantity
1
Total amount
$ 19
Gleevac | IKT-001 | NSC 759854 | ST-1571 | STI-571 | gleevec | glivec | imatinib | imitinib
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.